GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Halberd Corp (OTCPK:HALB) » Definitions » ROA %

Halberd (Halberd) ROA % : -3,131.03% (As of Jul. 2023)


View and export this data going back to 2009. Start your Free Trial

What is Halberd ROA %?

ROA % is calculated as Net Income divided by its average Total Assets over a certain period of time. Halberd's annualized Net Income for the quarter that ended in Jul. 2023 was $-0.45 Mil. Halberd's average Total Assets over the quarter that ended in Jul. 2023 was $0.01 Mil. Therefore, Halberd's annualized ROA % for the quarter that ended in Jul. 2023 was -3,131.03%.

The historical rank and industry rank for Halberd's ROA % or its related term are showing as below:

HALB' s ROA % Range Over the Past 10 Years
Min: -3131.03   Med: -905.29   Max: -10.53
Current: -3131.03

During the past 3 years, Halberd's highest ROA % was -10.53%. The lowest was -3131.03%. And the median was -905.29%.

HALB's ROA % is ranked worse than
99.68% of 1553 companies
in the Biotechnology industry
Industry Median: -34.84 vs HALB: -3131.03

Halberd ROA % Historical Data

The historical data trend for Halberd's ROA % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Halberd ROA % Chart

Halberd Annual Data
Trend Jul08 Jul22 Jul23
ROA %
-10.53 -905.29 -3,131.03

Halberd Semi-Annual Data
Jul08 Jul22 Jul23
ROA % -10.53 -905.29 -3,131.03

Competitive Comparison of Halberd's ROA %

For the Biotechnology subindustry, Halberd's ROA %, along with its competitors' market caps and ROA % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Halberd's ROA % Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Halberd's ROA % distribution charts can be found below:

* The bar in red indicates where Halberd's ROA % falls into.



Halberd ROA % Calculation

Halberd's annualized ROA % for the fiscal year that ended in Jul. 2023 is calculated as:

ROA %=Net Income (A: Jul. 2023 )/( (Total Assets (A: Jul. 2022 )+Total Assets (A: Jul. 2023 ))/ count )
=-0.454/( (0.017+0.012)/ 2 )
=-0.454/0.0145
=-3,131.03 %

Halberd's annualized ROA % for the quarter that ended in Jul. 2023 is calculated as:

ROA %=Net Income (Q: Jul. 2023 )/( (Total Assets (Q: Jul. 2022 )+Total Assets (Q: Jul. 2023 ))/ count )
=-0.454/( (0.017+0.012)/ 2 )
=-0.454/0.0145
=-3,131.03 %

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

In the calculation of annual ROA %, the net income of the last fiscal year and the average total assets over the fiscal year are used. In calculating the quarterly data, the Net Income data used here is one times the annual (Jul. 2023) net income data. ROA % is displayed in the 30-year financial page.


Halberd  (OTCPK:HALB) ROA % Explanation

ROA % measures the rate of return on the total assets (shareholder equity plus liabilities). It measures a firm's efficiency at generating profits from shareholders' equity plus its liabilities. ROA % shows how well a company uses what it has to generate earnings. ROA %s can vary drastically across industries. Therefore, ROA % should not be used to compare companies in different industries. For retailers, a ROA % of higher than 5% is expected. For example, Wal-Mart (WMT) has a ROA % of about 8% as of 2012. For banks, ROA % is close to their interest spread. A bank’s ROA % is typically well under 2%.

Similar to ROE, ROA % is affected by profit margins and asset turnover. This can be seen from the Du Pont Formula:

ROA %(Q: Jul. 2023 )
=Net Income/Total Assets
=-0.454/0.0145
=(Net Income / Revenue)*(Revenue / Total Assets)
=(-0.454 / 0.003)*(0.003 / 0.0145)
=Net Margin %*Asset Turnover
=-15133.33 %*0.2069
=-3,131.03 %

Note: The Net Income data used here is one times the annual (Jul. 2023) net income data. The Revenue data used here is one times the annual (Jul. 2023) revenue data.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Be Aware

Like ROE, ROA % is calculated with only 12 months data. Fluctuations in the company's earnings or business cycles can affect the ratio drastically. It is important to look at the ratio from a long term perspective. ROA % can be affected by events such as stock buyback or issuance, and by goodwill, a company's tax rate and its interest payment. ROA % may not reflect the true earning power of the assets. A more accurate measurement is ROC % (ROC).

Many analysts argue the higher return the better. Buffett states that really high ROA % may indicate vulnerability in the durability of the competitive advantage.

E.g. Raising $43b to take on KO is impossible, but $1.7b to take on Moody's is. Although Moody's ROA % and underlying economics is far superior to Coca Cola, the durability is far weaker because of lower entry cost.


Halberd ROA % Related Terms

Thank you for viewing the detailed overview of Halberd's ROA % provided by GuruFocus.com. Please click on the following links to see related term pages.


Halberd (Halberd) Business Description

Traded in Other Exchanges
N/A
Address
P.O. Box 25, Jackson Center, PA, USA, 16133
Halberd Corp is a research-based biotechnology company seeking to discover and develop medical treatments for a range of diseases. The Company's extracorporeal treatment is designed to treat hard-to-cure blood-borne, neurologic and infectious diseases. The Company's patented methodology removes the appropriate bodily fluid from the patient, in a continuous fashion, like dialysis, or in a batch process, like blood sample testing.
Executives
John Christopher Maddox director, 10 percent owner, officer: President, COO, Treasurer and, other: Interim CFO 10755 VERNON, HUNTINGTON WOODS MI 48070
Mark Sven Lundquist director, 10 percent owner, officer: CEO, Secretary and Director 24655 TUDOR LANE, FRANKLIN MI 48025
Cocco Nicholas A. Jr. director 50104 N. JIMMY COURT, CHESTERFIELD MI 48047-1898
Leland Michael Thomas director 280 LASALLE PLACE, GROSSE POINTE FARMS MI 88236